Promotion of Full-ThicknessWound Healing Using Epigallocatechin-3-O-Gallate/Poly (Lactic-Co-Glycolic Acid) Membrane as Temporary Wound Dressing

被引:30
作者
Kim, Hye-Lee [1 ,2 ]
Lee, Jeong-Hyun [1 ,2 ]
Kwon, Byeong Ju [1 ,2 ]
Lee, Mi Hee [1 ]
Han, Dong-Wook [3 ]
Hyon, Suong-Hyu [4 ]
Park, Jong-Chul [1 ,2 ]
机构
[1] Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea
[3] Pusan Natl Univ, Coll Nanosci & Nanotechnol, Dept Nanomed Engn, Pusan, South Korea
[4] Kyoto Inst Technol, Ctr Fiber & Text Sci, Kyoto 606, Japan
基金
新加坡国家研究基金会;
关键词
Epigallocatechin-3-O-gallate; Poly (lactic-co-glycolic acid); Temporary wound dressing; Wound healing; Electrospinning; GREEN TEA; GALLATE; SKIN;
D O I
10.1111/aor.12190
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Epigallocatechin-3-O-gallate (EGCG) is a major polyphenolic compound in green tea. It has been known that EGCG regulates the secretion of cytokines and the activation of skin cells during wound healing. In this study, various concentrations of EGCG were added to the electrospun membranes composed of poly (lactic-co-glycolic acid) (PLGA), and its healing effects on full-thickness wounds created in nude mice were investigated. The electrospun membranes containing 5 wt% EGCG (5EGCG/PLGA membrane) exhibited cytotoxicity in human dermal fibroblasts (HDFs) as HDF morphologies were transformed on them. In the animal study, cell infiltration of mice treated with electrospun membranes containing 1 wt% EGCG (1EGCG/PLGA membrane) significantly increased after 2 weeks. The immunoreactivity of Ki-67 (re-epithelialization at the wound site) and CD 31 (formation of blood vessels) also increased in the mice treated with 1EGCG/PLGA membranes in comparison with the mice treated with PLGA membranes. These results suggest that 1EGCG/PLGA can enhance wound healing in full thickness by accelerating cell infiltration, re-epithelialization, and angiogenesis.
引用
收藏
页码:411 / 417
页数:7
相关论文
共 21 条
[1]  
[Anonymous], 2005, INTRO ELECTRONANOFIB
[2]   Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity [J].
Babich, H ;
Krupka, ME ;
Nissim, HA ;
Zuckerbraun, HL .
TOXICOLOGY IN VITRO, 2005, 19 (02) :231-242
[3]   Wound healing dressings and drug delivery systems: A review [J].
Boateng, Joshua S. ;
Matthews, Kerr H. ;
Stevens, Howard N. E. ;
Eccleston, Gillian M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (08) :2892-2923
[4]   WOUND-HEALING - ORAL AND TOPICAL ACTIVITY OF ALOE VERA [J].
DAVIS, RH ;
LEITNER, MG ;
RUSSO, JM ;
BYRNE, ME .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1989, 79 (11) :559-562
[5]   Wound healing: An overview of acute, fibrotic and delayed healing [J].
Diegelmann, RF ;
Evans, MC .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :283-289
[6]   Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate [J].
Dooley, Audrey ;
Xu Shi-Wen ;
Aden, Nima ;
Tranah, Thomas ;
Desai, Nirupa ;
Denton, Christopher P. ;
Abraham, David J. ;
Bruckdorfer, Richard .
RHEUMATOLOGY, 2010, 49 (11) :2024-2036
[7]   Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities [J].
Elbling, L ;
Weiss, RM ;
Teufelhofer, O ;
Uhl, M ;
Knasmueller, S ;
Schulte-Hermann, R ;
Berger, W ;
Mickshe, M .
FASEB JOURNAL, 2005, 19 (02) :807-+
[8]   Antioxidant Therapies for Wound Healing: A Clinical Guide to Currently Commercially Available Products [J].
Fitzmaurice, S. D. ;
Sivamani, R. K. ;
Isseroff, R. R. .
SKIN PHARMACOLOGY AND PHYSIOLOGY, 2011, 24 (03) :113-126
[9]   Green tea and the skin [J].
Hsu, S .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (06) :1049-1059
[10]  
Hsu S, 2002, ANTICANCER RES, V22, P4115